43 enterprises, 22 varieties and 61 batches of drugs were unqualified, and a large number of Chinese patent drugs were "recruited"

On July 22, Shandong Drug Administration issued the notice of drug quality sampling inspection of Shandong Drug Administration (issue 3, 2019), which pointed out that 61 batches of 22 varieties of drugs from 43 production (preparation) units did not meet the standard requirements after the sampling inspection The substandard products include purple perilla, cinnabar, Radix Aconiti Preparata, Radix Houttuyniae, Herba Houttuyniae, gastritis mixture, woodlouse worm, Tong Cao, Shugan Yu Bao pills, Amomum villosum, ginseng, dandelion, Akebia, vinegar, myrrh, fry purple seed, sauteed jujube seed, pinellia syrup, Bai Wei, white front, alum and so on, almost all Chinese traditional medicine (or Chinese patent medicine); meanwhile, unqualified enterprises include many Famous Chinese medicine manufacturer In order to strengthen the supervision of drug quality and ensure the safety of drug use by the public, the drug supervision and administration departments and inspection institutions at all levels of our province have carried out drug supervision and sampling inspection in the whole province According to the inspection of drug sampling in the whole province, the sampling inspection is hereby notified as follows: 1、 After verification and confirmation, 61 batches of 22 varieties of drugs from 43 production (preparation) units failed to meet the standard requirements through sampling inspection (see the appendix for details) 2、 Relevant municipal market supervision and administration departments have taken control measures such as sealing up, detaining, suspending sales and product recall for non-conforming products, and have filed or are investigating relevant production enterprises and sampled units according to relevant laws and regulations The investigation and punishment can be found on the website of relevant municipal market supervision and administration departments 3、 For the non-conforming products and the corresponding enterprises and units, the relevant municipal market supervision and administration departments shall strengthen supervision, urge them to find out the causes of the problems, formulate and implement rectification measures, and effectively eliminate the potential risks Notice is hereby given Appendix: list of 61 batches of non-conforming drugs (issue 3, 2019) XLS (Disclosure attribute: active disclosure) Shandong drug administration July 14, 2019